Skip to main content
Clinical Trials/NCT04448236
NCT04448236
Completed
Not Applicable

Effects on Muscle Strength After Blood Flow Restriction Resistance Exercise (BFR-RE) in Early In-patient Rehabilitation of Chronic Obstructive Pulmonary Disease Acute Exacerbation (COPDAE), a Single Blinded, Randomized Controlled Study

Hospital Authority, Hong Kong1 site in 1 country53 target enrollmentJune 10, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Hospital Authority, Hong Kong
Enrollment
53
Locations
1
Primary Endpoint
Change of Maximal Voluntary Isometric Contraction (MVIC) of Knee Extension of the Dominant Leg in 3 Weeks
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is a randomised controlled trial of the blood flow restriction resistance exercise (BFR-RE) for early rehabilitation of chronic obstructive pulmonary disease acute exacerbation (COPDAE) in the Haven of Hope Hospital.

BFR-RE was invented by Dr. Yoshiaki Sato in Japan 40 years ago. This exercise was newly introduced to the Physiotherapy Department of Haven of Hope Hospital in March, 2020 and not a routine common training in Hospital Authority. However, currently the "BFR-device" is in its 3rd generation. Under the guidance of a certified physiotherapist, a "low load intensity" can be used for resistance training to build up muscle mass and strength by applying the device over the thigh to partially limit the blood flow to the distal limb.

BFR-RE is well studied in athletes, elderlies and patients for rehabilitation after orthopaedics surgeries. A large amount of literature reveals BFR-RE with "low load intensity" shows comparable increase of muscle mass as "high load intensity" resistance training and more increase of muscle strength than those only undergoing "low load intensity" resistance training.

The objective of this study is to investigate the additional effects of 2-week BFR-RE in patients with COPDAE on top of the conventional in-patient rehabilitation training. The primary outcome is effect on localized muscle strength. The secondary outcomes include mobility function, systemic muscle strength as reflected by handgrip strength(HGS), health related quality of life, unplanned readmission to acute hospital rate within 1 month for COPDAE.

Detailed Description

Chronic obstructive pulmonary disease (COPD) is a prevalent disease around the world particularly in developed countries. COPD often has frequent admissions for acute exacerbation which increase the risks of mortality. Muscular dysfunction is one of extra-pulmonary morbidity of COPD. Reduced muscle strength is associated with increased mortality in moderate to severe COPD. However, at least 70% of 1-repetition maximum (1-RM) of weight is needed to achieve muscle growth in resistance training. This might not be feasible particularly to the patients admitted for COPD acute exacerbation (COPDAE). Blood flow restriction resistance training (BFR-RE), Kaatsu training, was developed by Dr. Yoshiaki Sato more than 40 years ago. The basic physiological mechanism of BFR-RE to increase muscle mass and strength is by metabolite accumulation, e.g. lactate. The metabolites lead to increase of serum growth hormone (GH) which promotes the collagen synthesis for tissue repair and recovery. The surge of GH leads to release of insulin-like growth factor (IGF-1) which is a protein related to muscle growth. IGF-1 contributes the muscle gain, which is a muscular anabolic process, by enhancing satellite cell proliferation. Concerning growth of muscle mass, BFR-RE leads to a comparable increase when compared to high load resistance exercise (HL-RE). However, concerning increase of muscle strength, BFR-RE is less effective in gain than that in HL- RE but more effective than that in low load resistance exercise (LL-RE) alone. Therefore, BFR-RE can be considered when HL- RE is not advisable. (e.g. frail elderly, post-operative rehabilitation, etc.) BFR-RE is well studied among healthy adult, elderly and musculoskeletal rehabilitation patients, but not in COPDAE patients. Standardized isotonic knee extension resistance training on alternate day with a load of 15-30% of 1-Repetition Maximum (1-RM) with "BFR-device" will be compared with the control arm having same set of exercise training without the device in COPDAE patient during 2-week of inpatient stay. Referred to previous study with 30% drop out rate estimation, 24 patients for each arm will be needed. Study period will be set to be 9 months or until expected recruitment achieved. Though there no adverse risk responses were reported in published randomized controlled trials in clinical populations in the literature, there are some expected transient perceptual type responses, e.g. dizziness, limb numbness, perceived exertion, delayed onset muscle soreness. There are no significant risks of complications if BFR-RE is prescribed by certified trainers who have knowledge of appropriate protocols and contraindications to the use of occlusive stimuli. The effect on muscle strength in COPDAE inpatient, which is not well studied in the literatures, will be the primary outcome of this study. The effect on mobility functions, systemic muscle strength, health related quality of life, unplanned readmission rate within 1 month of discharge for COPDAE, acceptability and feasibility of the BFR-RE will be evaluated as secondary outcomes.

Registry
clinicaltrials.gov
Start Date
June 10, 2020
End Date
December 9, 2020
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hospital Authority, Hong Kong
Responsible Party
Principal Investigator
Principal Investigator

LAU chung wai

Principal investigator

Hospital Authority, Hong Kong

Eligibility Criteria

Inclusion Criteria

  • COPD acute exacerbation (COPDAE) as the primary diagnosis for hospitalization or transfer to pulmonary wards of the Haven of Hope Hospital
  • Able to walk under supervision
  • Understand instruction in Cantonese and can give informed consent.

Exclusion Criteria

  • Concomitant acute cardiac event
  • Severe hypertension (BP \> 180/100)
  • History of venous thromboembolism
  • History of peripheral vascular disease
  • Absence of posterior tibial or dorsalis pedal pulse
  • History of revascularization of the extremity
  • History of lymphectomies
  • Extremities with dialysis access
  • Vascular grafting
  • Current extremity infection

Outcomes

Primary Outcomes

Change of Maximal Voluntary Isometric Contraction (MVIC) of Knee Extension of the Dominant Leg in 3 Weeks

Time Frame: baseline and 3 weeks (after 10-12 sessions of training)

To measure the change of the force-producing capabilities of a muscle group objectively during its isometric contraction condition which means muscle group under contraction with a constant velocity of joint motion and muscle length. Computer dynamometer will be used to measure the MVIC of the isometric knee extension of the dominant leg.

Secondary Outcomes

  • Change of Hand Grip Strength in 3 Weeks(baseline and 3 weeks (after 10-12 sessions of training))
  • Acceptability of Blood Flow Restriction Resistance Exercise(Acceptance scale will be assessed immediately after the program after 3 (after 10-12 sessions of training))
  • Change of Scores of Short Physical Performance Battery (SPPB) in 3 Weeks(baseline and 3 weeks (after 10-12 sessions of training))
  • Change of Health Related Quality of Life in 3 Weeks(baseline and 3 weeks (after 10-12 sessions of training))
  • 6-minute Walk Test Distance Gain(baseline and 3 weeks (after 10-12 sessions of training))
  • Average Pain Score of Each Training(pain score before, immediate and 5-minute post exercise;)
  • Reasons of Drop-out of Blood Flow Restriction Resistance Exercise(baseline to 3 weeks (after 10-12 sessions of training))
  • Feasibility of BFR Exercise(baseline and 3 weeks (after 10-12 sessions of training))
  • Unplanned Readmission Rate on 1 Month Post Discharge(1 month after the discharge of patients in the study)

Study Sites (1)

Loading locations...

Similar Trials